Effects of co-infection with hepatitis C virus and GB virus C on CD4 cell count and HIV-RNA level among HIV-infected patients treated with highly active antiretroviral therapy.
The effects of co-infection with hepatitis C virus (HCV) and GB virus C (GBV-C) on CD4 cell counts and plasma HIV-RNA levels has been investigated in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Patients co-infected with HCV and GBV-C experienced a CD4 cell increase during 4 years of HAART, whereas the increase stopped after 2 years in the other groups.
Voirin
Nicolas
N
Service de Biostatistiques, Centre Hospitalier Lyon-Sud et Laboratoire d'Epémiologie et Santé Public, Université Claud Bernard, Lyon, France.
Trépo
Christian
C
Estève
Jacques
J
Chevallier
Philippe
P
Ritter
Jacques
J
Fabry
Jacques
J
Vanhems
Philippe
P
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D005260:Female; D018178:Flaviviridae Infections / Q000150:complications / Q000276:immunology / Q000821:virology; D029407:GB virus C / Q000276:immunology*; D006678:HIV / Q000235:genetics / Q000254:growth & development; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006526:Hepatitis C / Q000150:complications* / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood
D019380:Anti-HIV Agents; D012367:RNA, Viral